STRUCTURE DE CONSTITUANTS MYCOBACTERIENS: RELATION AVEC L'ACTIVITE IMMUNOLOGIQUE.LEDERER E.1978; ANN. MICROBIOL.; FR.; DA. 1978; VOL. 129; NO 1; PP. 91-93Article

CORRELATION OF CHEMICAL STRUCTURE AND BIOLOGICAL ACTIVITY OF MYCOBACTERIAL CELL WALLS AND DERIVED LIPIDS = CORRELATION DE LA STRUCTURE CHIMIQUE ET DE L'ACTIVITE BIOLOGIQUE DES PAROIS DES MYCOBACTERIES ET DES LIPIDES ISOLESLEDERER E.1972; BIOCHEM. SOC. SYMP.; G.B.; DA. 1972; NO 35; PP. 321-331; BIBL. 1P.1/2Serial Issue

SUR LA PRESENCE DE DERIVES EPSILON -N-METHYLES DE LA LYSINE A L'ETAT LIBRE DANS NEUROSPORA CRASSAVILLANUEVA VR; LEDERER E.1974; PHYTOCHEMISTRY; G.B.; DA. 1974; VOL. 13; NO 10; PP. 2157-2160; ABS. ANGL.; BIBL. 25REF.Article

CHEMISTRY OF SYNTHETIC IMMUNOMODULANT MURAMYL PEPTIDESLEFRANCIER P; LEDERER E.1981; FORTSCHR. CHEM. ORG. NATURST.; ISSN 0071-7886; AUT; DA. 1981; VOL. 40; PP. 1-47; BIBL. 94 REF.Article

PAST, PRESENT AND FUTURE OF THE SYNTHETIC IMMUNOADJUVANT MDP AND ITS ANALOGSCHEDID L; LEDERER E.1978; BIOCHEM. PHARMACOL.; GBR; DA. 1978; VOL. 27; NO 18; PP. 2183-2186; BIBL. 38 REF.Article

Immunomodulation by muramyl peptides and trehalose diesters in experimental parasitologyLEDERER, E.International journal of immunotherapy. 1986, Vol 2, Num 4, pp 267-278, issn 0255-9625Article

STIMULATION OF THYMOCYTE MITOGENIC PROTEIN SECRETION AND OF CYTOSTATIC ACTIVITY OF MOUSE PERITONEAL MACROPHAGES BY TREHALOSE DIMYCOLATE AND MURAMYL-DIPEPTIDETENU JP; LEDERER E; PETIT JF et al.1980; EUROP. J. IMMUNOL.; DEU; DA. 1980; VOL. 10; NO 8; PP. 647-653; BIBL. 55 REF.Article

NON-SPECIFIC MIF-LIKE ACTIVITY INDUCED BY THE SYNTHETIC IMMUNOADJUVANT: N-ACETYL MURAMYL-L-ALANYL-D-ISOGLUTAMINE (MDP)ADAM A; SOUVANNAVONG V; LEDERER E et al.1978; BIOCHEM. BIOPHYS. RES. COMMUNIC.; USA; DA. 1978; VOL. 85; NO 2; PP. 684-690; BIBL. 23 REF.Article

SELECTIVE INHIBITIONS OF TRNA METHYLTRANSFERASES BY S-ADENOSYLHOMOCYSTEINE AND TWO OF ITS ANALOGUES = INHIBITIONS SELECTIVES DES ARNT METHYLTRANSFERASES PAR LA S-ADENOSYLHOMOCYSTEINE ET DEUX DE SES ANALOGUESHILDESHEIM J; GOGUILLON JF; LEDERER E et al.1973; F.E.B.S. LETTERS; NETHERL.; DA. 1973; VOL. 30; NO 2; PP. 177-180; BIBL. 23 REF.Serial Issue

IMMUNOTHERAPY OF EXPERIMENTAL CANCER WITH A MIXTURE OF SYNTHETIC MURAMYL DIPEPTIDE AND TREHALOSE DIMYCOLATEYARKONI E; LEDERER E; RAPP HJ et al.1981; INFECT. IMMUN.; ISSN 0019-9567; USA; DA. 1981; VOL. 32; NO 1; PP. 273-276; BIBL. 10 REF.Article

NOUVELLES ETUDES DE L'INHIBITION D'UNE TRNA N² GUANINE METHYLTRANSFERASE PAR DES ANALOGUES DE LA S-ADENOSYL-HOMOCYSTEINE ET DE LA S-ADENOSYL-METHIONINE.MICHELOT R; LEGRAVEREND M; FARRUGIA G et al.1976; BIOCHIMIE; FR.; DA. 1976; VOL. 58; NO 1-2; PP. 201-205; ABS. ANGL.; BIBL. 29 REF.Article

RELATIONSHIP BETWEEN CHEMICAL STRUCTURE AND ADJUVANT ACTIVITY OF SOME SYNTHETIC ANALOGUES OF N-ACETYL-MURAMYL-L-ALANYL-D-ISOGLUTAMINE (MDP).AUDIBERT F; CHEDID L; LEFRANCIER P et al.1977; ANN. IMMUNOL.; FR.; DA. 1977; VOL. 128; NO 3; PP. 653-661; ABS. FR.; BIBL. 1 P.Article

INTERNATIONAL SYMPOSIUM ON BACTERIAL IMMUNOSTIMULANTS (CHEMICAL STRUCTURE, MECANISMS OF ACTION, APPLICATIONS)CHEDID L; LANDY M; LEDERER E et al.1975; CELL. IMMUNOL.; U.S.A.; DA. 1975; VOL. 17; NO 1; PP. 315-318Article

THE EFFECT OF ADENOSINE ANALOGUES ON THE IN VITRO GROWTH OF TRYPANOSOMA CRUZINADLER JP; LEDERER E; WITTNER M et al.1982; TRANS. R. SOC. TROP. MED. HYG.; ISSN 0035-9203; GBR; DA. 1982; VOL. 76; NO 3; PP. 285-287; BIBL. 17 REF.Article

INDUCTION OF RESISTANCE TO SCHISTOSOMA MANSONI BY NATURAL CORD FACTOR AND SYNTHETIC LOWER HOMOLOGUESOLDS GR; CHEDID L; LEDERER E et al.1980; J. INFECT. DIS.; USA; DA. 1980; VOL. 141; NO 4; PP. 473-478; BIBL. 30 REF.Article

IMMUNOTHERAPY OF AN ASCITIC RAT HEPATOMA WITH CORD FACTOR (TREHALOSE-6,6'-DIMYCOLATE) AND SYNTHETIC ANALOGUESPIMM MV; BALDWIN RW; POLONSKY J et al.1979; INTERNATION. J. CANCER; CHE; DA. 1979; VOL. 24; NO 6; PP. 780-785; ABS. FRE; BIBL. 27 REF.Article

THE ANTIFUNGAL ANTIBIOTIC SINEFUNGIN AS A VERY ACTIVE INHIBITOR OF METHYLTRANSFERASES AND OF THE TRANSFORMATION OF CHICK EMBRYO FIBROBLASTS BY ROUS SARCOMA VIRUSVEDEL M; LAWRENCE F; ROBERT GERO M et al.1978; BIOCHEM. BIOPHYS. RES. COMMUNIC.; USA; DA. 1978; VOL. 85; NO 1; PP. 371-376; BIBL. 17 REF.Article

IMMUNOTHERAPY OF CANCER WITH NONLIVING BCG AND FRACTIONS DERIVED FROM MYCOBACTERIA: ROLE OF CORD FACTOR (TREHALOSE-6,6PRIME -DIMYCOLATE) IN TUMOR REGRESSIONBEKIERKUNST A; WANG L; TOUBIANA R et al.1974; INFECT. AND IMMUN.; U.S.A.; DA. 1974; VOL. 10; NO 5; PP. 1044-1050; BIBL. 1P.Article

THE AMINO ACIDS OF THE CELL WALL OF MYCOBACTERIUM TUBERCULOSIS VAR. BOVIS, STRAIN BCG: PRESENCE OF A POLY (L-GLUTAMIC ACID)WIETZERBIN FALSZPAN J; DAS BC; GROS C et al.1973; EUROP. J. BIOCHEM.; GERM.; DA. 1973; VOL. 32; NO 3; PP. 525-532; BIBL. 34REF.Serial Issue

REGRESSION OF A MURINE FIBROSARCOMA AFTER INTRALESIONAL INJECTION OF A SYNTHETIC C39 GLYCOLIPID RELATED TO CORD FACTORYARKONI E; RAPP HJ; POLONSKY J et al.1979; INFECT. AND IMMUN.; USA; DA. 1979; VOL. 26; NO 2; PP. 462-466; BIBL. 17 REF.Article

MODULATION OF THE IMMUNE RESPONSE BY A SYNTHETIC ADJUVANT AND ANALOGE.CHEDID L; AUDIBERT F; LEFRANCIER P et al.1976; PROC. NATION. ACAD. SCI. U.S.A.; U.S.A.; DA. 1976; VOL. 73; NO 7; PP. 2472-2475; BIBL. 17 REF.Article

CELL WALLS OF MYCOBACTERIA AND RELATED ORGANISMS. CHEMISTRY AND IMMUNOSTIMULANT PROPERTIESLEDERER E; ADAM A; CIORBARU R et al.1975; MOLEC. CELL. BIOCHEM.; NETHERL.; DA. 1975; VOL. 7; NO 2; PP. 87-104; BIBL. 3 P. 1/2Article

IN VIVO AND IN VITRO STIMULATION OF NONSPECIFIC IMMUNITY BY THE BETA -D-P-AMINOPHENYL GLYCOSIDE OF N-ACETYLMURAMYL-L-ALANYL-D-ISOGLUTAMINE AND AN OLIGOMER PREPARED BY CROSS-LINKING WITH GLUTARALDEHYDEPARANT M; DAMAIS C; AUDIBERT F et al.1978; J. INFECT. DIS.; USA; DA. 1978; VOL. 138; NO 3; PP. 378-386; BIBL. 25 REF.Article

INDUCTION OF INTERFERON SYNTHESIS IN MICE BY FRACTIONS FROM NOCARDIA.BAROT CIORBARV R; WIETZERBIN J; PETIT JF et al.1978; INFECT. AND IMMUN.; U.S.A.; DA. 1978; VOL. 19; NO 2; PP. 353-356; BIBL. 15 REF.Article

CANCEROGENESE ET PHARMACOLOGIE DU CANCERLEDERER E; CHEDID L.1978; ; FRA; DA. 1978; DGRST 76 7 1678; 4-(10) P.; 30 CM; ACTION CONCERT.: CANCEROGENESE PHARMACOL. CANCERReport